We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

89 hedge funds and large institutions have $7.36M invested in Alaunos Therapeutics in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,609% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $11K

0.03% less ownership

Funds ownership: 0.19% → 0.16% (-0.03%)

11% less funds holding

Funds holding: 100 → 89 (-11)

61% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 28

65% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 17

78% less capital invested

Capital invested by funds: $34.2M → $7.36M (-$26.9M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
89
Holders Change
-11
Holders Change %
-11%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
6
Increased
11
Reduced
28
Closed
17
Calls
$1.07M
Puts
$11K
Net Calls
+$1.06M
Net Calls Change
-$2.87M

Top Buyers

Rank Fund Capital Flow
1
MCA
Magnolia Capital Advisors
Mississippi
+$124K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$93.9K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$21.4K
4
TSS
Two Sigma Securities
New York
+$12.2K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.33K

Top Sellers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
-$2.92M
2
JP Morgan Chase
JP Morgan Chase
New York
-$694K
3
GCP
GSA Capital Partners
United Kingdom
-$262K
4
Renaissance Technologies
Renaissance Technologies
New York
-$256K
5
BC
Boxer Capital
California
-$115K
Name Holding Trade Value Shares
Change 		Change in
Stake
Victory Capital Management
51
Victory Capital Management
Texas
$3.31K +$388 +9 +6%
Creative Planning
52
Creative Planning
Kansas
$3.26K – – –
GT
53
Glenmede Trust
Pennsylvania
$2.64K – – –
SFG
54
SevenBridge Financial Group
Pennsylvania
$2.64K – – –
NAS
55
Nicolet Advisory Services
Wisconsin
$2.36K – – –
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
$2.12K – – –
ProShare Advisors
57
ProShare Advisors
Maryland
$2.07K +$43 +1 +1%
CW
58
CreativeOne Wealth
Kansas
$2K – – –
SI
59
Stephens Inc
Arkansas
$2K – – –
VCAM
60
Van Cleef Asset Management
Ohio
$1.9K +$4.14K +96 New
BFG
61
Bleakley Financial Group
New Jersey
$1.88K -$86 -2 -2%
SS
62
Simplicity Solutions
Minnesota
$1.88K -$86 -2 -2%
CAN
63
Cetera Advisor Networks
California
$1.73K +$258 +6 +7%
Jane Street
64
Jane Street
New York
$1.67K +$3.62K +84 New
HCM
65
Hudson Capital Management
New Jersey
$1.58K – – –
OL
66
Owen LaRue
Kentucky
$1.56K – – –
CPIG
67
Chicago Partners Investment Group
Illinois
$1.54K – – –
ODG
68
O'Dell Group
Ohio
$1.34K – – –
FCH
69
Freestone Capital Holdings
Washington
$1.32K – – –
ADL
70
Asset Dedication LLC
California
$1K – – –
HI
71
Harbour Investments
Wisconsin
$923 – – –
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$840 – – –
CUAMC
73
China Universal Asset Management Company
China
$815 +$862 +20 +95%
BF
74
BOK Financial
Oklahoma
$800 – – –
NFSG
75
Newbridge Financial Services Group
Florida
$501 -$603 -14 -36%
1 2
3
4 5

TCRT Hedge Fund Activity: Q3 2023 in Review

89 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q3 2023, worth a combined $7.36M — down 78% from $34.2M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of TCRT and 6 opened new positions — a net loss of 11 holders — while 28 trimmed existing stakes and 11 added.

The largest buyer was Magnolia Capital Advisors, opening a new position worth an estimated $124K. The largest seller was Laurion Capital Management, exiting entirely with an estimated $2.92M sold.

  • 89 institutional investors held Alaunos Therapeutics (TCRT) as of Q3 2023, down from 100 in Q2 2023.
  • Funds reported $7.36M of Alaunos Therapeutics stock for Q3 2023, down 78% quarter-over-quarter.
  • 6 funds opened new Alaunos Therapeutics positions in Q3 2023 and 17 closed out, a net change of -11 holders.
  • The largest Alaunos Therapeutics buyer in Q3 2023 was Magnolia Capital Advisors, an estimated $124K added.
  • The largest Alaunos Therapeutics seller in Q3 2023 was Laurion Capital Management, an estimated $2.92M sold.

Based on aggregated 13F filings for Q3 2023.